Messa Law Recall Report

Personal injury attorneys working to keep people safe from dangerous and defective products.

  • About
  • Contact Us
  • CPSC RECALLS
  • FDA RECALLS
Copyright © 2014 Messa & Associates | All Rights Reserved
You are here: Home / FDA / FDA issues warning to Abbott Laboratories regarding manufacturing flaws of several cardiovascular devices

FDA issues warning to Abbott Laboratories regarding manufacturing flaws of several cardiovascular devices

04/21/2017 By Angela Leone Leave a Comment

On April 12, 2017, Abbott Laboratories received a letter from the U.S. Food and Drug Administration warning them about manufacturing flaws regarding several cardiovascular devices acquired through their January 2017 purchase of St. Jude Medical for $25 billion.

The FDA stated that the company failed to disclose at least one death that was associated with one of the defective cardiovascular devices and that an inspection in a California facility raised troubling questions about the safety of several defibrillators and portable heart monitors.

The inspection uncovered dangerous leaking of lithium batteries in a number of devices and a serious underestimation of the occurrence of the dangerous situation.

Abbott released a statement claiming a “strong history and commitment to product safety and quality.” The company also stated that the inspection took place in February and that the issues raised were addressed in a March 13th letter to the FDA which described all corrective actions taken.

“We take these matters seriously, continue to make progress on our corrective actions, will closely review FDA’s warning letter, and are committed to fully addressing FDA’s concerns,” the company said.

The FDA stated that Abbott failed to provide evidence that the corrective actions they claimed to implement were actually implemented.

Affected Devices

The devices affected by the leakin lithium batteries – implantable cardioverter defibrillators (ICDs) and Cardiac Resynchronization Therapy Defibrillators (CRT-Ds) – help regulate heart rhythms.

In October, before they were acquired by Abbott Laboratories, St. Jude said it would recall certain devices due to battery failure caused by lithium leakage. Abbot Laboratories has not moved forward with that recall.

New Jersey and Philadelphia Personal Injury Attorneys

The Philadelphia personal injury attorneys at Messa & Associates are experienced with cases involving defective products.  If you or a loved one has been injured by a defective or faulty product, contact the Philadelphia personal injury attorneys at Messa & Associates, P.C. for a free consultation by calling 877-MessaLaw. You can also submit an inquiry online for a free case evaluation.  Let Messa & Associates earn you the compensation you deserve.

Share this:

  • Facebook
  • Twitter
  • LinkedIn

Filed Under: FDA, medical device

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Recent Posts

  • Nissan Altimas Recalled Over Fire, Stall Risks
  • 1.7 Million Toyota Vehicles Recalled for Potentially Deadly Airbags
  • 1.6M BMWs Recalled Due to Fire Hazards
  • Nearly 7 Million Pounds of Beef Recalled Due to Potential Salmonella Contamination
  • Ford, Toyota recall over 3M vehicles due to fire hazards

RSS Latest Recalls

  • Mockingbird Expands Recall to Include Single Strollers Due to Fall Hazard 03/17/2023
  • IKEA Recalls Mirrors Due to Laceration Hazard 03/16/2023
  • Polaris Recalls Sportsman All-Terrain Vehicles Due to Fire and Crash Hazards (Recall Alert) 03/16/2023